' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | OncLive serves as a connection to everything oncology, including interviews and videos from thought leaders and cutting edge articles and resources on cancer. |
h1 tags | All Oncology News |
h2 tags | Latest Oncology News Mature Data Drive New Insights With Novel Agents in Breast Cancer Personalized Medicine Is Gaining Momentum in Advanced Endometrial Cancer FDA Grants Regular Approval to Enfortumab Vedotin, Expands Indication for Locally Advanced or Metastatic Urothelial Cancer Urologic Care Rates Decline Across US Demographics During Height of COVID-19 Pandemic Lenvatinib/Pembrolizumab’s Favorable HRQoL Leads to “Standout” Option for Frontline RCC Latest Oncology Videos Usmani Underscores New and Updated Data Across Myeloma Paradigm Copanlisib/Rituximab Combination Demonstrates Superiority Across iNHL Galinpepimut-S Plus Pembrolizumab Shows Early Activity in Advanced Ovarian Cancer Survival Advantages in Metastatic Breast Cancer Move the Needle Toward Curative-Intent Strategies ASCO 2021 Brings Increasing Recognition of Health Disparities in Cancer Care Emerging Immune Checkpoint Research Focuses on CD137 CTCA Leaders Provide Post-Pandemic Predictions in Oncology COVID-19 Vaccination Induces High Seroconversion Rates in Patients With Cancer, But Novel Strategies Needed for Select Subsets Bekaii-Saab Breaks Down Significant Developments in the Realm of Gastrointestinal Cancers Melphalan Flufenamide Shows Mixed Findings in Relapsed/Refractory Myeloma, Leads to Partial Clinical Hold New Toolkit Aims to Help Employers Address Cancer Treatment In-Home Infusions Could Continue to Bridge Disparities in Cancer Care Introducing the Post-Pandemic Change With Lung Cancer Screening Dr. Shah on Efforts to Combat Resistance to BTK Inhibitors in MCL Dr. Wong on Treatment Goals in Systemic Amyloidosis |
Site Speed | 0.30693793296814 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| onclive.com | A | IN | 59 | |
| onclive.com | A | IN | 59 | |
| onclive.com | NS | IN | 21599 | ns-1350.awsdns-40.org |
| onclive.com | NS | IN | 21599 | ns-140.awsdns-17.com |
| onclive.com | NS | IN | 21599 | ns-1699.awsdns-20.co.uk |
| onclive.com | NS | IN | 21599 | ns-796.awsdns-35.net |
| onclive.com | SOA | IN | 899 | |
| onclive.com | MX | IN | 299 | us-smtp-inbound-1.mimecast.com |
| onclive.com | MX | IN | 299 | us-smtp-inbound-2.mimecast.com |
| onclive.com | TXT | IN | 299 | |
| onclive.com | TXT | IN | 299 | |
| onclive.com | TXT | IN | 299 | |
| onclive.com | TXT | IN | 299 | |
| onclive.com | TXT | IN | 299 |